scholarly journals Comparative changes in plasma concentrations of progesterone, oestradiol and LH during the ovulatory cycle in a multiple ovulating male line and a single ovulating traditional line of turkeys

Reproduction ◽  
2002 ◽  
pp. 127-133 ◽  
Author(s):  
S Buchanan ◽  
GW Robertson ◽  
PM Hocking
Keyword(s):  
Peak Plasma ◽  
Ovarian Tissue ◽  
Plasma Concentrations ◽  
High Growth ◽  
Correlated Response ◽  
Ovulatory Cycle ◽  
Plasma Progesterone ◽  
Multiple Ovulation ◽  
Male Line ◽  
The Mean

The aim of this study was to compare the profile of circulating concentrations of LH, progesterone and oestradiol in a multiple ovulating male line with that of a single ovulating line of traditional turkeys. Plasma samples from seven traditional and 12 male-line turkeys were obtained every 3 h for 36 h. Male-line and traditional turkeys had single peaks of LH and progesterone that were of similar duration in both lines. The mean height of the plasma peaks of LH and progesterone were similar in the two lines and there was no detectable peak plasma oestrogen concentration. Mean plasma concentrations of LH and oestrogen were higher in single compared with multiple ovulating turkeys, whereas there were no differences in mean plasma progesterone concentrations. The results indicate that the multiple ovulation state in genetically selected high-growth lines of turkey may be the result of a correlated response in the steroidogenic capacity of ovarian tissue associated with low plasma concentrations of oestrogen rather than of a disturbance in the hormone profile of the ovulatory cycle.

Ibuprofen: Plasma Concentrations in Man

1985 ◽  
Vol 13 (1) ◽  
pp. 68-73 ◽  
Author(s):  
G M E Janssen ◽  
J F Venema
Keyword(s):  
Side Effects ◽  
Crossover Study ◽  
Plasma Levels ◽  
Healthy Subjects ◽  
Peak Plasma ◽  
Plasma Concentrations ◽  
Repeated Dose ◽  
Similar Range ◽  
The Mean ◽  
Peak Value

The plasma levels of Ibuprofen were measured in five healthy subjects who took 600 mg tablets of Ibuprofen twice daily, three times daily and four times daily in a crossover study. Peak plasma levels were obtained 1 hour after the first dose in all but one subject (slow absorber), the mean peak value being 51·3 μg.ml−1 (range 39·4–63·7 μg.ml−1). After the repeated dose regimens of two, three or four times daily of ibuprofen, the peak levels achieved were in a similar range to those seen after the first dose: Twice daily 39·4–66·4 μg.ml−1 Three times daily 43·6–63·3 μg.ml−1 Four times daily 44·1–58·4 μg.ml−1 There was no evidence of accumulation of the drug and no side-effects occurred during the trial.

Attenuation of preovulatory gonadotrophin surges by epostane: a new inhibitor of 3β-hydroxysteroid dehydrogenase

1988 ◽  
Vol 118 (1) ◽  
pp. 59-68 ◽  
Author(s):  
L. V. DePaolo
Keyword(s):  
Peak Plasma ◽  
Plasma Concentrations ◽  
Hydroxysteroid Dehydrogenase ◽  
Inhibitory Effects ◽  
Plasma Progesterone ◽  
Ru 486 ◽  
Progesterone Secretion ◽  
Progesterone Antagonist

ABSTRACT Epostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, was administered orally to pro-oestrous rats to evaluate further a possible role for preovulatory progesterone secretion in eliciting surges of LH and FSH. Whereas a dose of 10 mg epostane/kg had essentially no effects on preovulatory gonadotrophin surges and ovulation, 200 mg epostane/kg markedly attenuated LH and FSH surges and blocked ovulation. A dose of 50 mg epostane/kg exerted effects on LH and FSH surges and ovulation intermediate between those of doses of 10 and 200 mg/kg. Plasma concentrations of progesterone were significantly lower in all anovulatory epostane-treated rats at 18.00 and 22.00 h on pro-oestrus than those measured in vehicle-treated rats. Concurrent injection of 2 mg progesterone in rats given 200 mg epostane/kg restored gonadotrophin surges to normal, but consistently failed to reverse the inhibitory effects of epostane on ovulation. Peak plasma progesterone levels produced by the progesterone injections were eight- to tenfold higher than the highest levels measured in vehicle-treated rats during the afternoon of pro-oestrus. Insertion of progesterone capsules was less effective than injections of progesterone in restoring gonadotrophin surges to normal, even though peak plasma progesterone concentrations achieved after insertion of two 20 mm long progesterone capsules were double the peak progesterone concentrations measured in control rats. Nevertheless, taken together with recent reports showing attenuation of preovulatory gonadotrophin surges by the progesterone antagonist RU 486 (17β-hydroxy-11β-[4-dimethyl-aminophenyl]-17α-[prop-1-ynl]estra-4,9-diene-3-one), the present results provide support for a role of preovulatory progesterone secretion in enhancing oestrogen-dependent LH/FSH surges on pro-oestrus. J. Endocr. (1988) 118, 59–68

scholarly journals Pharmacokinetic and Pharmacodynamic Evaluation of Marbofloxacin in Pig against Korean Local Isolates ofActinobacillus pleuropneumoniae

2017 ◽  
Vol 2017 ◽  
pp. 1-11 ◽  
Author(s):  
Md. Akil Hossain ◽  
Hae-chul Park ◽  
Kyunghun Jeong ◽  
Yang ho Jang ◽  
Dae Gyun Kim ◽  
...  
Keyword(s):  
Body Weight ◽  
Ex Vivo ◽  
Peak Plasma ◽  
Plasma Concentrations ◽  
Antibacterial Activities ◽  
Time Intervals ◽  
Concentration Time ◽  
Elimination Half ◽  
The Mean

The pharmacokinetics of marbofloxacin in pigs after intravenous (i.v.), intramuscular (i.m.), and peroral (p.o.) administration and pharmacokinetic/pharmacodynamic indices of this drug against Korean local isolates ofActinobacillus pleuropneumoniaewere determined in this study. Marbofloxacin (2.50 mg/kg of body weight) was administered, and blood samples were collected with designated time intervals. Plasma-extracted marbofloxacin was injected into the LC-MS/MS system. The in vitro and ex vivo antibacterial activities of marbofloxacin were evaluated against 20 isolates ofA. pleuropneumoniae. The mean peak plasma concentrations (Cmax) after i.v., i.m., and p.o administration were2.60±0.10,2.59±0.12, and2.34±0.12 µg/mL at0.25±0.00,0.44±0.10, and1.58±0.40 h, respectively. The area under the plasma concentration-time curves (AUC0–24) and elimination half-lives were24.80±0.90,25.80±1.40, and23.40±5.00 h·μg/mL and8.60±0.30,12.80±1.10, and8.60±0.00 h, for i.v., i.m., and p.o. administration, correspondingly. The AUC0–24/MICs of marbofloxacin after i.v., i.m., and p.o. administration were253.86±179.91,264.1±187.16, and239.53±169.75 h, respectively. TheCmax/MIC values were26.58±18.84,26.48±18.77, and23.94±16.97, and T>MICs were42.80±1.01,36.40±1.24, and38.60±1.18 h, after i.v., i.m., and p.o. administration, respectively. Thus, marbofloxacin dosage of 2.50 mg/kg of body weight by i.v., i.m., and p.o. administration with 24 h dosing interval will provide effective treatment for the infection of pig byA. pleuropneumonia.

CHANGES IN PLASMA CONCENTRATIONS OF LUTEINIZING HORMONE AFTER INJECTION OF PROGESTERONE AT VARIOUS TIMES DURING THE OVULATORY CYCLE OF THE DOMESTIC HEN (GALLUS DOMESTICUS)

1975 ◽  
Vol 67 (1) ◽  
pp. 59-70 ◽  
Author(s):  
SUSAN C. WILSON ◽  
P. J. SHARP
Keyword(s):  
Luteinizing Hormone ◽  
Plasma Concentrations ◽  
Gallus Domesticus ◽  
Ovulatory Cycle ◽  
Lh Surge ◽  
Incremental Change ◽  
The Mean ◽  
Domestic Hen

SUMMARY Changes in plasma LH concentrations after i.m. injections of 0·5 mg progesterone/kg at various stages of the ovulatory cycle were measured by radioimmunoassay. Four types of response were observed. (1) When the steroid was injected between 4 h after and 12 h before an ovulation, LH levels started to rise after 15–45 min and reached peak values within 90–120 min. The mean maximal incremental change in the level of LH was 1·58 ± 0·10 (s.e.m.) ng/ml (n = 37). (2) In contrast, when progesterone was injected 12–8 h before ovulation, i.e. immediately before a spontaneous pre-ovulatory LH surge, the resulting mean maximal incremental change in LH level, 0·79 ± 0·12 ng/ml (n = 9), was significantly smaller (P < 0·001). (3) If progesterone was injected 8–4 h before ovulation, i.e. when pre-ovulatory LH levels were rising, they immediately started to rise more rapidly and reached peak values within 45 min. The maximal incremental change in the level of LH under these circumstances, 2·34 ± 0·20 ng/ml (n = 12), was significantly greater (P < 0·001 in both cases) than the changes observed in the responses 1 and 2 described above. (4) Levels of LH generally showed no incremental change in response to injections of progesterone given 4–0 h before ovulation, i.e. when pre-ovulatory LH levels were falling. It was concluded that the type of change in plasma LH levels induced by progesterone depended upon the stage of the ovulatory cycle at which the steroid was injected.

scholarly journals Characterization of Oestrus Cycles in Namibian Swakara and Damara Sheep through Determination of Circannual Plasma Progesterone Levels

2019 ◽  
Vol 2019 ◽  
pp. 1-6 ◽  
Author(s):  
Erick Kandiwa ◽  
Borden Mushonga ◽  
Oscar Madzingira ◽  
Alaster Samkange ◽  
Alec Bishi ◽  
...  
Keyword(s):  
Seasonal Variation ◽  
Gradual Increase ◽  
Peak Plasma ◽  
Average Length ◽  
Area Under The Curve ◽  
Plasma Progesterone ◽  
The Mean ◽  
Uniform Plasma

A year-long prospective study characterized the seasonality of oestrus cycles in primiparous, nonpregnant Swakara (n=8) and Damara (n=5) ewes through surveillance of plasma progesterone (P4) levels. During this period, Swakara and Damara groups evidently averaged 23 oestrus cycles with an average length of 17 days. Damara ewes showed greater mean peak plasma P4 levels (11.4±0.16ng/ml) than Swakara ewes (5.4±0.11ng/ml) (P<0.05). Oestrus cycles in Damara ewes showed relatively uniform plasma P4 peaks throughout the year ranging from 10.6±0.16 to 12.6±0.24ng/ml. In Swakara ewes, P4 peaks were highest in the autumn oestrus cycles (from 7.1±0.16 to 7.5±0.11ng/ml), rapidly declining through winter to 2.2±0.08ng/ml by midspring and then rapidly increasing to 4.9±0.37ng/ml at the commencement of summer, followed by a gradual increase from 5.7± to 7.1±ng/ml by the start of autumn. The annual mean area under the curve temporal progesterone measurements (AUCPM) in Damara ewes (115.9±18.6ng⁎day/ml) was greater than that in Swakara ewes (58.6±25.3ng⁎day/ml) (p<0.05). For Swakara ewes, the mean AUCPM in summer and autumn cycles (68.2±14.7 and 79.5±10.0ng⁎day/ml, respectively) were greater than those in spring and winter cycles (28.7±12.3 and 55.0±27.3ng⁎day/ml), respectively (P<0.05). There was no seasonal variation in the exposure of the Damara ewes to P4 in between seasons (P>0.05), though, however, the Damara ewes had greater P4 levels than the Swakara ewes (P<0.05). Progesterone profiles showed that Swakara ewes possessed ‘residual’ seasonality, whereas the Damara ewes were no longer seasonal. The implications of this disparity in the seasonal exposure of Swakara and Damara ewes to luteal P4 on fertility warrant further investigation.

Bioavailability of Temazepam: Comparison of Four 7.5-mg Capsules with a Single 30-mg Capsule

1993 ◽  
Vol 27 (6) ◽  
pp. 695-699 ◽  
Author(s):  
Craig Abolin ◽  
Dar-Shong Hwang ◽  
Frank Mazza
Keyword(s):  
Peak Concentration ◽  
Dosage Form ◽  
Peak Plasma ◽  
Statistical Significance ◽  
Plasma Concentrations ◽  
Latin Square ◽  
Open Label ◽  
Time To Peak ◽  
Rate Of Absorption ◽  
The Mean

OBJECTIVE: To compare the bioavailability of four temazepam 7.5-mg capsules (Restoril, Sandoz Pharmaceuticals) with that of a single temazepam 30-mg capsule. DESIGN: Single-dose, open-label, two-period, crossover (replicated Latin square). SETTING: Domiciled environment for clinical testing. PARTICIPANTS: Twenty-six healthy male volunteers aged 18–40 years; 25 completed the study. INTERVENTIONS: Subjects randomly received either four temazepam 7.5-mg capsules or one temazepam 30-mg capsule. Blood samples were drawn at various time points after each period (0-48 h), and analyzed for plasma concentration of temazepam. The washout period between doses was five days. MAIN OUTCOME MEASUREMENTS: Five parameters of both dosage forms were compared: (1) area under curve (AUC), (2) peak concentration (Cmax), (3) time to peak concentration (Tmax), (4) apparent rate constant for absorption, and (5) lag time for appearance of drug in plasma. Statistical procedures included ANOVA, power analysis, and confidence limits. RESULTS: The mean AUC for the four 7.5-mg capsules and one 30-mg capsule differed by less than 2 percent and the mean Cmax differed by less than 14 percent for the two dosage strengths; neither of these differences reached statistical significance (p>0.05). The 7.5-mg capsules reached peak plasma concentrations significantly faster than the 30-mg dosage form (mean Tmax 1.18 and 1.73 h, respectively; p=0.01). CONCLUSIONS: The two formulations of temazepam were bioequivalent with respect to the extent of bioavailability. Regarding the rate of absorption, however, the 7.5-mg capsules reached peak plasma concentrations significantly faster than the 30-mg dosage form.

Plasma concentrations of progesterone, oestradiol-17β and 13,14-dihydro-15-oxo-prostaglandin F2α in the pregnant wallaby (Macropus rufogriseus rufogriseus)

1983 ◽  
Vol 97 (3) ◽  
pp. 369-377 ◽  
Author(s):  
M. T. Walker ◽  
R. T. Gemmell
Keyword(s):  
Plasma Concentrations ◽  
Prostaglandin F2α ◽  
Maternal Plasma ◽  
Gestation Length ◽  
Birth Process ◽  
Plasma Progesterone ◽  
Prostaglandin F ◽  
The Mean ◽  
Uterine Secretions ◽  
Mean Concentration

The concentrations of progesterone and oestradiol-17β in the maternal plasma of Bennett's wallaby, Macropus rufogriseus rufogriseus, were measured daily throughout gestation after reactivation of the diapausing corpus luteum by removal of the suckling pouch young (RPY). Progesterone increased from mean concentrations of 382–424 pmol/l (120–133 pg/ml) during lactation to reach peak concentrations of 908 ± 172 (s.e.m.) pmol/l (285 ± 54 pg/ml) (n = 8) 4 days after RPY and 971 ± 220 and 971 ± 229 pmol/l (305 ± 69 and 305 ± 72 pg/ml) (n = 7) 24 and 25 days after RPY respectively. The mean gestation length (RPY to birth) was 26·8 ± 0·6 (s.d.) days (n = 6, range 25·75–27·50 days). Immediately after birth the plasma progesterone concentration declined to 299 ± 51 (s.e.m.) pmol/l (94 ± 16 pg/ml) (n=6). Oestradiol-17β increased from mean concentrations of 291–553 pmol/l (80–152 pg/ml) during lactation to reach a peak concentration of 967 ± 331 pmol/l (266 ± 91 pg/ml) (n = 9) 1 day after RPY. The concentration declined from 7 days after RPY and fluctuated between mean concentrations of 273 and 480 pmol/l before reaching a minimum of 207 ± 69 pmol/l (57 ± 19 pg/ml) (n = 6) 19 days after RPY. A transient increase to 542 ± 207 pmol/l (n = 7) occurred at 22 days after RPY. Plasma concentrations declined to a low of 156 ± 55 pmol/l (43 ± 15 pg/ml) (n = 6) 5 days after parturition. The mean concentration of plasma 13,14-dihydro-15-oxo-prostaglandin F2α was less than 2·8 nmol/l (1 ng/ml) for all samples from 13 days after RPY until 4 days after parturition. The results suggest that oestradiol-17β may be important in the early stages of blastocyst reactivation to synergize with progesterone in stimulating uterine secretions. 13,14-Dihydro-15-oxo-prostaglandin F2α is unlikely to be involved in the birth process and any luteolytic effect is likely to be from a local production of PGF2α.

Influence of liver fat on post-partum hormone profiles in dairy cows

1987 ◽  
Vol 45 (1) ◽  
pp. 9-14 ◽  
Author(s):  
Elaine D. Watson ◽  
Linda A. Williams
Keyword(s):  
Dairy Cows ◽  
Jugular Vein ◽  
Peak Plasma ◽  
Post Partum ◽  
Fatty Infiltration ◽  
Plasma Concentrations ◽  
Liver Fat ◽  
Plasma Progesterone ◽  
Liver Biopsies ◽  
The Difference

AbstractCows (no. = 11) were classified from liver biopsies taken 7 to 10 days after calving as having mild (FL1, no. = 6), or moderate (FL2, no. = 5) fatty infiltration of the liver. Blood samples were collected from the jugular vein: (1) three times weekly and assayed for progesterone and oestradiol; (2) at 10-min intervals for 8-h periods on three occasions during the early post-partum period and assayed for LH; (3) every 2 h, with ovarian palpation performed every 4 h around the second or third post-partum ovulation, and assayed for LH and oestradiol.Mean weekly concentrations of oestradiol were not significantly different between FL1 and FL2 cows. FL2 cows tended to have short (< 17 days) first cycles (3/4 FL2 v. 0/5 FL1) with significantly lower concentrations of plasma progesterone (P < 0·05). Mean basal concentrations of LH in the samples collected at 10-min intervals tended to be lower in FL2 than in FL1 cows; however, the difference was significant only in the 2nd week of sampling (P = 0·05). Mean basal concentrations of LH were significantly higher in weeks 3 and 4 than in week 2 in FL1 but not in FL2 cows (P < 0·05). The frequency and amplitude of LH pulses were not affected by week of sampling or by fat content of the liver. The total area under the profile of LH during the pre-ovulatory surge was lower in FL2 than in FL1 cows (P < 0·05) but peak plasma concentrations of pre-ovulatory oestradiol and timing of ovulation after the LH surge were similar.

scholarly journals Effects of the Antifungals Voriconazole and Fluconazole on the Pharmacokinetics of S-(+)- and R-(−)-Ibuprofen

2006 ◽  
Vol 50 (6) ◽  
pp. 1967-1972 ◽  
Author(s):  
Ville-Veikko Hynninen ◽  
Klaus T. Olkkola ◽  
Kari Leino ◽  
Stefan Lundgren ◽  
Pertti J. Neuvonen ◽  
...  
Keyword(s):  
Plasma Concentration ◽  
Peak Plasma ◽  
Peak Plasma Concentration ◽  
Geometric Mean ◽  
Plasma Concentrations ◽  
Time Curve ◽  
Respective Control ◽  
Control Value ◽  
Racemic Ibuprofen ◽  
The Mean

ABSTRACT Our objective was to study the effects of the antifungals voriconazole and fluconazole on the pharmacokinetics of S-(+)- and R-(−)-ibuprofen. Twelve healthy male volunteers took a single oral dose of 400 mg racemic ibuprofen in a randomized order either alone, after ingestion of voriconazole at 400 mg twice daily on the first day and 200 mg twice daily on the second day, or after ingestion of fluconazole at 400 mg on the first day and 200 mg on the second day. Ibuprofen was ingested 1 h after administration of the last dose of voriconazole or fluconazole. Plasma concentrations of S-(+)- and R-(−)-ibuprofen were measured for up to 24 h. In the voriconazole phase, the mean area under the plasma concentration-time curve (AUC) of S-(+)-ibuprofen was 205% (P < 0.001) of the respective control value and the mean peak plasma concentration (C max) was 122% (P < 0.01) of the respective control value. The mean elimination half-life (t 1/2) was prolonged from 2.4 to 3.2 h (P < 0.01) by voriconazole. In the fluconazole phase, the mean AUC of S-(+)-ibuprofen was 183% of the control value (P < 0.001) and its mean C max was 116% of the control value (P < 0.05). The mean t 1/2 of S-(+)-ibuprofen was prolonged from 2.4 to 3.1 h (P < 0.05) by fluconazole. The geometric mean S-(+)-ibuprofen AUC ratios in the voriconazole and fluconazole phases were 2.01 (90% confidence interval [CI], 1.80 to 2.22) and 1.82 (90% CI, 1.72 to 1.91), respectively, i.e., above the bioequivalence acceptance upper limit of 1.25. Voriconazole and fluconazole had only weak effects on the pharmacokinetics of R-(−)-ibuprofen. In conclusion, voriconazole and fluconazole increased the levels of exposure to S-(+)-ibuprofen 2- and 1.8-fold, respectively. This was likely caused by inhibition of the cytochrome P450 2C9-mediated metabolism of S-(+)-ibuprofen. A reduction of the ibuprofen dosage should be considered when ibuprofen is coadministered with voriconazole or fluconazole, especially when the initial ibuprofen dose is high.

Sign in / Sign up

Export Citation Format

Share Document